EarningsQ3 2025 Earnings Report

Recursion Pharmaceuticals (RXRX) Q3 2025 Earnings Report

7 Followers

MX:RXRX Q3 2025 EPS Results

Actual EPS-$6.51

Consensus EPS-$6.82

Beat/MissBeat by +$0.31

One Year Ago EPS-$6.15

Actual Revenue$93.64M

Expected Revenue$306.72M

Beat/MissMissed by -$213.07M

YoY Revenue Growth-80.16%

QuarterQ3 2025

Date11/05/2025

TimeBefore Open

Conference CallWednesday, November 5, 2025

MX:RXRX Upcoming Earnings

Recursion Pharmaceuticals's next earnings date is estimated for November 11, 2026, based on past reporting schedules.

MX:RXRX Q3 2025 Earnings Call

0:00 / 0:00

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Nov 11, 2026	2026 (Q3)	-3.98 / -	-6.514	―
Aug 05, 2026	2026 (Q2)	-4.34 / -4.52	-7.419	39.02% (+2.90)
May 06, 2026	2026 (Q1)	-4.80 / -3.98	-9.048	56.00% (+5.07)
Feb 25, 2026	2025 (Q4)	-5.45 / -3.80	-9.591	60.38% (+5.79)
Nov 05, 2025	2025 (Q3)	-6.82 / -6.51	-6.152	-5.88% (-0.36)
Aug 05, 2025	2025 (Q2)	-6.39 / -7.42	-7.238	-2.50% (-0.18)
May 05, 2025	2025 (Q1)	-9.34 / -9.05	-7.057	-28.21% (-1.99)
Feb 28, 2025	2024 (Q4)	-7.44 / -9.59	-7.6	-26.19% (-1.99)
Nov 06, 2024	2024 (Q3)	-6.03 / -6.15	-7.781	20.93% (+1.63)
Aug 08, 2024	2024 (Q2)	-6.95 / -7.24	-6.876	-5.26% (-0.36)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed